nodes	percent_of_prediction	percent_of_DWPC	metapath
Simvastatin—SLCO1A2—Chlorambucil—testicular cancer	0.129	0.151	CbGbCtD
Simvastatin—UGT2B7—Epirubicin—testicular cancer	0.0707	0.083	CbGbCtD
Simvastatin—UGT1A1—Etoposide—testicular cancer	0.0476	0.0559	CbGbCtD
Simvastatin—CYP3A7—Ifosfamide—testicular cancer	0.0405	0.0475	CbGbCtD
Simvastatin—CYP3A7-CYP3A51P—Ifosfamide—testicular cancer	0.0405	0.0475	CbGbCtD
Simvastatin—CYP2B6—Ifosfamide—testicular cancer	0.0386	0.0452	CbGbCtD
Simvastatin—ABCC2—Carboplatin—testicular cancer	0.0345	0.0405	CbGbCtD
Simvastatin—ABCC2—Vinblastine—testicular cancer	0.0322	0.0377	CbGbCtD
Simvastatin—CYP3A5—Ifosfamide—testicular cancer	0.0304	0.0356	CbGbCtD
Simvastatin—ABCC2—Cisplatin—testicular cancer	0.0295	0.0346	CbGbCtD
Simvastatin—CYP2C8—Ifosfamide—testicular cancer	0.0292	0.0343	CbGbCtD
Simvastatin—ABCC2—Etoposide—testicular cancer	0.029	0.034	CbGbCtD
Simvastatin—CYP2C19—Ifosfamide—testicular cancer	0.0245	0.0287	CbGbCtD
Simvastatin—SLCO1A2—Methotrexate—testicular cancer	0.0231	0.0271	CbGbCtD
Simvastatin—SLCO1B1—Methotrexate—testicular cancer	0.0218	0.0256	CbGbCtD
Simvastatin—CYP2C9—Ifosfamide—testicular cancer	0.0204	0.0239	CbGbCtD
Simvastatin—ABCC2—Doxorubicin—testicular cancer	0.0198	0.0232	CbGbCtD
Simvastatin—ABCC2—Methotrexate—testicular cancer	0.0191	0.0225	CbGbCtD
Simvastatin—CYP2B6—Cisplatin—testicular cancer	0.0188	0.022	CbGbCtD
Simvastatin—ABCB1—Dactinomycin—testicular cancer	0.0167	0.0196	CbGbCtD
Simvastatin—CYP3A5—Etoposide—testicular cancer	0.0145	0.017	CbGbCtD
Simvastatin—CYP2C8—Etoposide—testicular cancer	0.014	0.0164	CbGbCtD
Simvastatin—CYP2B6—Doxorubicin—testicular cancer	0.0126	0.0147	CbGbCtD
Simvastatin—CYP3A4—Ifosfamide—testicular cancer	0.0118	0.0139	CbGbCtD
Simvastatin—ABCB1—Vinblastine—testicular cancer	0.0105	0.0123	CbGbCtD
Simvastatin—CYP2C9—Cisplatin—testicular cancer	0.00991	0.0116	CbGbCtD
Simvastatin—CYP2D6—Vinblastine—testicular cancer	0.00988	0.0116	CbGbCtD
Simvastatin—ABCB1—Cisplatin—testicular cancer	0.00962	0.0113	CbGbCtD
Simvastatin—ABCB1—Etoposide—testicular cancer	0.00945	0.0111	CbGbCtD
Simvastatin—ABCB1—Doxorubicin—testicular cancer	0.00644	0.00756	CbGbCtD
Simvastatin—CYP3A4—Vinblastine—testicular cancer	0.00628	0.00737	CbGbCtD
Simvastatin—ABCB1—Methotrexate—testicular cancer	0.00624	0.00732	CbGbCtD
Simvastatin—CYP2D6—Doxorubicin—testicular cancer	0.00607	0.00712	CbGbCtD
Simvastatin—CYP3A4—Etoposide—testicular cancer	0.00566	0.00664	CbGbCtD
Simvastatin—CYP3A4—Doxorubicin—testicular cancer	0.00386	0.00453	CbGbCtD
Simvastatin—Eosinophilia—Methotrexate—testicular cancer	0.000228	0.00155	CcSEcCtD
Simvastatin—Nausea—Vinblastine—testicular cancer	0.000228	0.00155	CcSEcCtD
Simvastatin—Anorexia—Cisplatin—testicular cancer	0.000228	0.00155	CcSEcCtD
Simvastatin—Gastrointestinal pain—Ifosfamide—testicular cancer	0.000227	0.00154	CcSEcCtD
Simvastatin—Pancreatitis—Methotrexate—testicular cancer	0.000226	0.00153	CcSEcCtD
Simvastatin—Discomfort—Etoposide—testicular cancer	0.000226	0.00153	CcSEcCtD
Simvastatin—Toxic epidermal necrolysis—Epirubicin—testicular cancer	0.000225	0.00153	CcSEcCtD
Simvastatin—Hypersensitivity—Dactinomycin—testicular cancer	0.000223	0.00151	CcSEcCtD
Simvastatin—Abdominal discomfort—Methotrexate—testicular cancer	0.000221	0.0015	CcSEcCtD
Simvastatin—Gastritis—Epirubicin—testicular cancer	0.000221	0.0015	CcSEcCtD
Simvastatin—Confusional state—Etoposide—testicular cancer	0.000221	0.0015	CcSEcCtD
Simvastatin—Muscular weakness—Epirubicin—testicular cancer	0.00022	0.00149	CcSEcCtD
Simvastatin—Urticaria—Ifosfamide—testicular cancer	0.00022	0.00149	CcSEcCtD
Simvastatin—Abdominal pain—Ifosfamide—testicular cancer	0.000219	0.00149	CcSEcCtD
Simvastatin—Body temperature increased—Ifosfamide—testicular cancer	0.000219	0.00149	CcSEcCtD
Simvastatin—Anaphylactic shock—Etoposide—testicular cancer	0.000219	0.00149	CcSEcCtD
Simvastatin—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.000218	0.00148	CcSEcCtD
Simvastatin—Infection—Etoposide—testicular cancer	0.000217	0.00148	CcSEcCtD
Simvastatin—Asthenia—Dactinomycin—testicular cancer	0.000217	0.00147	CcSEcCtD
Simvastatin—Paraesthesia—Cisplatin—testicular cancer	0.000215	0.00146	CcSEcCtD
Simvastatin—Thrombocytopenia—Etoposide—testicular cancer	0.000214	0.00145	CcSEcCtD
Simvastatin—Upper respiratory tract infection—Methotrexate—testicular cancer	0.000214	0.00145	CcSEcCtD
Simvastatin—Eosinophilia—Epirubicin—testicular cancer	0.000214	0.00145	CcSEcCtD
Simvastatin—Dyspnoea—Cisplatin—testicular cancer	0.000213	0.00145	CcSEcCtD
Simvastatin—Erectile dysfunction—Methotrexate—testicular cancer	0.000212	0.00144	CcSEcCtD
Simvastatin—Pancreatitis—Epirubicin—testicular cancer	0.000212	0.00144	CcSEcCtD
Simvastatin—Photosensitivity reaction—Methotrexate—testicular cancer	0.00021	0.00143	CcSEcCtD
Simvastatin—Anorexia—Etoposide—testicular cancer	0.000209	0.00142	CcSEcCtD
Simvastatin—Toxic epidermal necrolysis—Doxorubicin—testicular cancer	0.000208	0.00141	CcSEcCtD
Simvastatin—Decreased appetite—Cisplatin—testicular cancer	0.000208	0.00141	CcSEcCtD
Simvastatin—Bronchitis—Epirubicin—testicular cancer	0.000207	0.00141	CcSEcCtD
Simvastatin—Diarrhoea—Dactinomycin—testicular cancer	0.000207	0.0014	CcSEcCtD
Simvastatin—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000206	0.0014	CcSEcCtD
Simvastatin—Vomiting—Bleomycin—testicular cancer	0.000206	0.0014	CcSEcCtD
Simvastatin—Depression—Methotrexate—testicular cancer	0.000205	0.00139	CcSEcCtD
Simvastatin—Rash—Bleomycin—testicular cancer	0.000204	0.00139	CcSEcCtD
Simvastatin—Gastritis—Doxorubicin—testicular cancer	0.000204	0.00139	CcSEcCtD
Simvastatin—Pain—Cisplatin—testicular cancer	0.000204	0.00139	CcSEcCtD
Simvastatin—Dermatitis—Bleomycin—testicular cancer	0.000204	0.00139	CcSEcCtD
Simvastatin—Hypersensitivity—Ifosfamide—testicular cancer	0.000204	0.00139	CcSEcCtD
Simvastatin—Stevens-Johnson syndrome—Methotrexate—testicular cancer	0.000204	0.00138	CcSEcCtD
Simvastatin—Muscular weakness—Doxorubicin—testicular cancer	0.000204	0.00138	CcSEcCtD
Simvastatin—Upper respiratory tract infection—Epirubicin—testicular cancer	0.000201	0.00136	CcSEcCtD
Simvastatin—Asthenia—Ifosfamide—testicular cancer	0.000199	0.00135	CcSEcCtD
Simvastatin—Eosinophilia—Doxorubicin—testicular cancer	0.000198	0.00134	CcSEcCtD
Simvastatin—Photosensitivity reaction—Epirubicin—testicular cancer	0.000197	0.00134	CcSEcCtD
Simvastatin—Feeling abnormal—Cisplatin—testicular cancer	0.000197	0.00134	CcSEcCtD
Simvastatin—Paraesthesia—Etoposide—testicular cancer	0.000197	0.00133	CcSEcCtD
Simvastatin—Pruritus—Ifosfamide—testicular cancer	0.000196	0.00133	CcSEcCtD
Simvastatin—Pancreatitis—Doxorubicin—testicular cancer	0.000196	0.00133	CcSEcCtD
Simvastatin—Dyspnoea—Etoposide—testicular cancer	0.000195	0.00132	CcSEcCtD
Simvastatin—Nausea—Bleomycin—testicular cancer	0.000193	0.00131	CcSEcCtD
Simvastatin—Vomiting—Dactinomycin—testicular cancer	0.000192	0.00131	CcSEcCtD
Simvastatin—Bronchitis—Doxorubicin—testicular cancer	0.000192	0.0013	CcSEcCtD
Simvastatin—Stevens-Johnson syndrome—Epirubicin—testicular cancer	0.000191	0.00129	CcSEcCtD
Simvastatin—Rash—Dactinomycin—testicular cancer	0.000191	0.00129	CcSEcCtD
Simvastatin—Decreased appetite—Etoposide—testicular cancer	0.00019	0.00129	CcSEcCtD
Simvastatin—Diarrhoea—Ifosfamide—testicular cancer	0.00019	0.00129	CcSEcCtD
Simvastatin—Gastrointestinal disorder—Etoposide—testicular cancer	0.000189	0.00128	CcSEcCtD
Simvastatin—Body temperature increased—Cisplatin—testicular cancer	0.000189	0.00128	CcSEcCtD
Simvastatin—Fatigue—Etoposide—testicular cancer	0.000189	0.00128	CcSEcCtD
Simvastatin—Neuropathy peripheral—Epirubicin—testicular cancer	0.000189	0.00128	CcSEcCtD
Simvastatin—Jaundice—Epirubicin—testicular cancer	0.000188	0.00127	CcSEcCtD
Simvastatin—Pain—Etoposide—testicular cancer	0.000187	0.00127	CcSEcCtD
Simvastatin—Constipation—Etoposide—testicular cancer	0.000187	0.00127	CcSEcCtD
Simvastatin—Upper respiratory tract infection—Doxorubicin—testicular cancer	0.000186	0.00126	CcSEcCtD
Simvastatin—Hepatitis—Methotrexate—testicular cancer	0.000185	0.00125	CcSEcCtD
Simvastatin—Dizziness—Ifosfamide—testicular cancer	0.000183	0.00124	CcSEcCtD
Simvastatin—Photosensitivity reaction—Doxorubicin—testicular cancer	0.000182	0.00124	CcSEcCtD
Simvastatin—Sinusitis—Epirubicin—testicular cancer	0.00018	0.00123	CcSEcCtD
Simvastatin—Feeling abnormal—Etoposide—testicular cancer	0.00018	0.00122	CcSEcCtD
Simvastatin—Nausea—Dactinomycin—testicular cancer	0.00018	0.00122	CcSEcCtD
Simvastatin—Gastrointestinal pain—Etoposide—testicular cancer	0.000179	0.00122	CcSEcCtD
Simvastatin—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.000176	0.0012	CcSEcCtD
Simvastatin—Vomiting—Ifosfamide—testicular cancer	0.000176	0.0012	CcSEcCtD
Simvastatin—Hypersensitivity—Cisplatin—testicular cancer	0.000176	0.00119	CcSEcCtD
Simvastatin—Rash—Ifosfamide—testicular cancer	0.000175	0.00119	CcSEcCtD
Simvastatin—Dermatitis—Ifosfamide—testicular cancer	0.000175	0.00119	CcSEcCtD
Simvastatin—Erythema multiforme—Methotrexate—testicular cancer	0.000174	0.00118	CcSEcCtD
Simvastatin—Neuropathy peripheral—Doxorubicin—testicular cancer	0.000174	0.00118	CcSEcCtD
Simvastatin—Urticaria—Etoposide—testicular cancer	0.000174	0.00118	CcSEcCtD
Simvastatin—Jaundice—Doxorubicin—testicular cancer	0.000174	0.00118	CcSEcCtD
Simvastatin—Abdominal pain—Etoposide—testicular cancer	0.000173	0.00117	CcSEcCtD
Simvastatin—Body temperature increased—Etoposide—testicular cancer	0.000173	0.00117	CcSEcCtD
Simvastatin—Hepatitis—Epirubicin—testicular cancer	0.000173	0.00117	CcSEcCtD
Simvastatin—Asthenia—Cisplatin—testicular cancer	0.000171	0.00116	CcSEcCtD
Simvastatin—Sinusitis—Doxorubicin—testicular cancer	0.000167	0.00113	CcSEcCtD
Simvastatin—Chills—Methotrexate—testicular cancer	0.000166	0.00112	CcSEcCtD
Simvastatin—Nausea—Ifosfamide—testicular cancer	0.000165	0.00112	CcSEcCtD
Simvastatin—Diarrhoea—Cisplatin—testicular cancer	0.000163	0.00111	CcSEcCtD
Simvastatin—Erythema multiforme—Epirubicin—testicular cancer	0.000163	0.00111	CcSEcCtD
Simvastatin—Alopecia—Methotrexate—testicular cancer	0.000163	0.00111	CcSEcCtD
Simvastatin—Mental disorder—Methotrexate—testicular cancer	0.000162	0.0011	CcSEcCtD
Simvastatin—Hypersensitivity—Etoposide—testicular cancer	0.000161	0.00109	CcSEcCtD
Simvastatin—Erythema—Methotrexate—testicular cancer	0.000161	0.00109	CcSEcCtD
Simvastatin—Flushing—Epirubicin—testicular cancer	0.00016	0.00109	CcSEcCtD
Simvastatin—Hepatitis—Doxorubicin—testicular cancer	0.00016	0.00108	CcSEcCtD
Simvastatin—Dysgeusia—Methotrexate—testicular cancer	0.000157	0.00107	CcSEcCtD
Simvastatin—Asthenia—Etoposide—testicular cancer	0.000157	0.00107	CcSEcCtD
Simvastatin—Chills—Epirubicin—testicular cancer	0.000155	0.00105	CcSEcCtD
Simvastatin—Pruritus—Etoposide—testicular cancer	0.000155	0.00105	CcSEcCtD
Simvastatin—Alopecia—Epirubicin—testicular cancer	0.000153	0.00104	CcSEcCtD
Simvastatin—Vomiting—Cisplatin—testicular cancer	0.000152	0.00103	CcSEcCtD
Simvastatin—Vision blurred—Methotrexate—testicular cancer	0.000151	0.00103	CcSEcCtD
Simvastatin—Mental disorder—Epirubicin—testicular cancer	0.000151	0.00103	CcSEcCtD
Simvastatin—Erythema multiforme—Doxorubicin—testicular cancer	0.000151	0.00103	CcSEcCtD
Simvastatin—Rash—Cisplatin—testicular cancer	0.000151	0.00102	CcSEcCtD
Simvastatin—Dermatitis—Cisplatin—testicular cancer	0.000151	0.00102	CcSEcCtD
Simvastatin—Erythema—Epirubicin—testicular cancer	0.00015	0.00102	CcSEcCtD
Simvastatin—Diarrhoea—Etoposide—testicular cancer	0.00015	0.00102	CcSEcCtD
Simvastatin—Ill-defined disorder—Methotrexate—testicular cancer	0.000149	0.00101	CcSEcCtD
Simvastatin—Anaemia—Methotrexate—testicular cancer	0.000148	0.00101	CcSEcCtD
Simvastatin—Flushing—Doxorubicin—testicular cancer	0.000148	0.00101	CcSEcCtD
Simvastatin—Flatulence—Epirubicin—testicular cancer	0.000148	0.00101	CcSEcCtD
Simvastatin—Dysgeusia—Epirubicin—testicular cancer	0.000147	0.000999	CcSEcCtD
Simvastatin—Malaise—Methotrexate—testicular cancer	0.000145	0.000983	CcSEcCtD
Simvastatin—Dizziness—Etoposide—testicular cancer	0.000145	0.000983	CcSEcCtD
Simvastatin—Muscle spasms—Epirubicin—testicular cancer	0.000145	0.000981	CcSEcCtD
Simvastatin—Vertigo—Methotrexate—testicular cancer	0.000144	0.00098	CcSEcCtD
Simvastatin—Leukopenia—Methotrexate—testicular cancer	0.000144	0.000976	CcSEcCtD
Simvastatin—Chills—Doxorubicin—testicular cancer	0.000143	0.000973	CcSEcCtD
Simvastatin—Nausea—Cisplatin—testicular cancer	0.000142	0.000963	CcSEcCtD
Simvastatin—Vision blurred—Epirubicin—testicular cancer	0.000142	0.000962	CcSEcCtD
Simvastatin—Alopecia—Doxorubicin—testicular cancer	0.000141	0.000959	CcSEcCtD
Simvastatin—Mental disorder—Doxorubicin—testicular cancer	0.00014	0.00095	CcSEcCtD
Simvastatin—Ill-defined disorder—Epirubicin—testicular cancer	0.000139	0.000947	CcSEcCtD
Simvastatin—Vomiting—Etoposide—testicular cancer	0.000139	0.000945	CcSEcCtD
Simvastatin—Erythema—Doxorubicin—testicular cancer	0.000139	0.000944	CcSEcCtD
Simvastatin—Anaemia—Epirubicin—testicular cancer	0.000139	0.000943	CcSEcCtD
Simvastatin—Rash—Etoposide—testicular cancer	0.000138	0.000937	CcSEcCtD
Simvastatin—Dermatitis—Etoposide—testicular cancer	0.000138	0.000936	CcSEcCtD
Simvastatin—Headache—Etoposide—testicular cancer	0.000137	0.000931	CcSEcCtD
Simvastatin—Flatulence—Doxorubicin—testicular cancer	0.000137	0.000931	CcSEcCtD
Simvastatin—Chest pain—Methotrexate—testicular cancer	0.000137	0.000928	CcSEcCtD
Simvastatin—Arthralgia—Methotrexate—testicular cancer	0.000137	0.000928	CcSEcCtD
Simvastatin—Myalgia—Methotrexate—testicular cancer	0.000137	0.000928	CcSEcCtD
Simvastatin—Dysgeusia—Doxorubicin—testicular cancer	0.000136	0.000925	CcSEcCtD
Simvastatin—Malaise—Epirubicin—testicular cancer	0.000136	0.00092	CcSEcCtD
Simvastatin—Discomfort—Methotrexate—testicular cancer	0.000135	0.000917	CcSEcCtD
Simvastatin—Vertigo—Epirubicin—testicular cancer	0.000135	0.000917	CcSEcCtD
Simvastatin—Leukopenia—Epirubicin—testicular cancer	0.000135	0.000914	CcSEcCtD
Simvastatin—Muscle spasms—Doxorubicin—testicular cancer	0.000134	0.000908	CcSEcCtD
Simvastatin—Confusional state—Methotrexate—testicular cancer	0.000132	0.000897	CcSEcCtD
Simvastatin—Anaphylactic shock—Methotrexate—testicular cancer	0.000131	0.00089	CcSEcCtD
Simvastatin—Vision blurred—Doxorubicin—testicular cancer	0.000131	0.00089	CcSEcCtD
Simvastatin—Infection—Methotrexate—testicular cancer	0.00013	0.000884	CcSEcCtD
Simvastatin—Nausea—Etoposide—testicular cancer	0.00013	0.000883	CcSEcCtD
Simvastatin—Ill-defined disorder—Doxorubicin—testicular cancer	0.000129	0.000876	CcSEcCtD
Simvastatin—Anaemia—Doxorubicin—testicular cancer	0.000129	0.000873	CcSEcCtD
Simvastatin—Thrombocytopenia—Methotrexate—testicular cancer	0.000128	0.000871	CcSEcCtD
Simvastatin—Arthralgia—Epirubicin—testicular cancer	0.000128	0.000869	CcSEcCtD
Simvastatin—Myalgia—Epirubicin—testicular cancer	0.000128	0.000869	CcSEcCtD
Simvastatin—Chest pain—Epirubicin—testicular cancer	0.000128	0.000869	CcSEcCtD
Simvastatin—Anxiety—Epirubicin—testicular cancer	0.000128	0.000866	CcSEcCtD
Simvastatin—Discomfort—Epirubicin—testicular cancer	0.000126	0.000858	CcSEcCtD
Simvastatin—Malaise—Doxorubicin—testicular cancer	0.000125	0.000852	CcSEcCtD
Simvastatin—Vertigo—Doxorubicin—testicular cancer	0.000125	0.000848	CcSEcCtD
Simvastatin—Anorexia—Methotrexate—testicular cancer	0.000125	0.000848	CcSEcCtD
Simvastatin—Leukopenia—Doxorubicin—testicular cancer	0.000125	0.000845	CcSEcCtD
Simvastatin—Confusional state—Epirubicin—testicular cancer	0.000124	0.00084	CcSEcCtD
Simvastatin—Anaphylactic shock—Epirubicin—testicular cancer	0.000123	0.000833	CcSEcCtD
Simvastatin—Oedema—Epirubicin—testicular cancer	0.000123	0.000833	CcSEcCtD
Simvastatin—Infection—Epirubicin—testicular cancer	0.000122	0.000827	CcSEcCtD
Simvastatin—Thrombocytopenia—Epirubicin—testicular cancer	0.00012	0.000816	CcSEcCtD
Simvastatin—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000119	0.000811	CcSEcCtD
Simvastatin—Insomnia—Methotrexate—testicular cancer	0.000119	0.000805	CcSEcCtD
Simvastatin—Myalgia—Doxorubicin—testicular cancer	0.000118	0.000804	CcSEcCtD
Simvastatin—Arthralgia—Doxorubicin—testicular cancer	0.000118	0.000804	CcSEcCtD
Simvastatin—Chest pain—Doxorubicin—testicular cancer	0.000118	0.000804	CcSEcCtD
Simvastatin—Anxiety—Doxorubicin—testicular cancer	0.000118	0.000801	CcSEcCtD
Simvastatin—Paraesthesia—Methotrexate—testicular cancer	0.000118	0.000799	CcSEcCtD
Simvastatin—Discomfort—Doxorubicin—testicular cancer	0.000117	0.000794	CcSEcCtD
Simvastatin—Anorexia—Epirubicin—testicular cancer	0.000117	0.000794	CcSEcCtD
Simvastatin—Dyspnoea—Methotrexate—testicular cancer	0.000117	0.000793	CcSEcCtD
Simvastatin—Dyspepsia—Methotrexate—testicular cancer	0.000115	0.000783	CcSEcCtD
Simvastatin—Confusional state—Doxorubicin—testicular cancer	0.000114	0.000777	CcSEcCtD
Simvastatin—Decreased appetite—Methotrexate—testicular cancer	0.000114	0.000774	CcSEcCtD
Simvastatin—Oedema—Doxorubicin—testicular cancer	0.000114	0.000771	CcSEcCtD
Simvastatin—Anaphylactic shock—Doxorubicin—testicular cancer	0.000114	0.000771	CcSEcCtD
Simvastatin—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000113	0.000768	CcSEcCtD
Simvastatin—Fatigue—Methotrexate—testicular cancer	0.000113	0.000767	CcSEcCtD
Simvastatin—Infection—Doxorubicin—testicular cancer	0.000113	0.000766	CcSEcCtD
Simvastatin—Pain—Methotrexate—testicular cancer	0.000112	0.000761	CcSEcCtD
Simvastatin—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000112	0.000759	CcSEcCtD
Simvastatin—Thrombocytopenia—Doxorubicin—testicular cancer	0.000111	0.000755	CcSEcCtD
Simvastatin—Insomnia—Epirubicin—testicular cancer	0.000111	0.000753	CcSEcCtD
Simvastatin—Paraesthesia—Epirubicin—testicular cancer	0.00011	0.000748	CcSEcCtD
Simvastatin—Dyspnoea—Epirubicin—testicular cancer	0.000109	0.000743	CcSEcCtD
Simvastatin—Anorexia—Doxorubicin—testicular cancer	0.000108	0.000735	CcSEcCtD
Simvastatin—Feeling abnormal—Methotrexate—testicular cancer	0.000108	0.000733	CcSEcCtD
Simvastatin—Dyspepsia—Epirubicin—testicular cancer	0.000108	0.000733	CcSEcCtD
Simvastatin—Gastrointestinal pain—Methotrexate—testicular cancer	0.000107	0.000728	CcSEcCtD
Simvastatin—Decreased appetite—Epirubicin—testicular cancer	0.000107	0.000724	CcSEcCtD
Simvastatin—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000106	0.000719	CcSEcCtD
Simvastatin—Fatigue—Epirubicin—testicular cancer	0.000106	0.000718	CcSEcCtD
Simvastatin—Pain—Epirubicin—testicular cancer	0.000105	0.000712	CcSEcCtD
Simvastatin—Constipation—Epirubicin—testicular cancer	0.000105	0.000712	CcSEcCtD
Simvastatin—Urticaria—Methotrexate—testicular cancer	0.000104	0.000707	CcSEcCtD
Simvastatin—Abdominal pain—Methotrexate—testicular cancer	0.000104	0.000704	CcSEcCtD
Simvastatin—Body temperature increased—Methotrexate—testicular cancer	0.000104	0.000704	CcSEcCtD
Simvastatin—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000103	0.000702	CcSEcCtD
Simvastatin—Insomnia—Doxorubicin—testicular cancer	0.000103	0.000697	CcSEcCtD
Simvastatin—Paraesthesia—Doxorubicin—testicular cancer	0.000102	0.000692	CcSEcCtD
Simvastatin—Dyspnoea—Doxorubicin—testicular cancer	0.000101	0.000687	CcSEcCtD
Simvastatin—Feeling abnormal—Epirubicin—testicular cancer	0.000101	0.000686	CcSEcCtD
Simvastatin—Gastrointestinal pain—Epirubicin—testicular cancer	0.0001	0.000681	CcSEcCtD
Simvastatin—Dyspepsia—Doxorubicin—testicular cancer	9.99e-05	0.000678	CcSEcCtD
Simvastatin—Decreased appetite—Doxorubicin—testicular cancer	9.87e-05	0.00067	CcSEcCtD
Simvastatin—Gastrointestinal disorder—Doxorubicin—testicular cancer	9.8e-05	0.000665	CcSEcCtD
Simvastatin—Fatigue—Doxorubicin—testicular cancer	9.79e-05	0.000664	CcSEcCtD
Simvastatin—Urticaria—Epirubicin—testicular cancer	9.75e-05	0.000662	CcSEcCtD
Simvastatin—Constipation—Doxorubicin—testicular cancer	9.71e-05	0.000659	CcSEcCtD
Simvastatin—Pain—Doxorubicin—testicular cancer	9.71e-05	0.000659	CcSEcCtD
Simvastatin—Abdominal pain—Epirubicin—testicular cancer	9.7e-05	0.000658	CcSEcCtD
Simvastatin—Body temperature increased—Epirubicin—testicular cancer	9.7e-05	0.000658	CcSEcCtD
Simvastatin—Hypersensitivity—Methotrexate—testicular cancer	9.66e-05	0.000656	CcSEcCtD
Simvastatin—Asthenia—Methotrexate—testicular cancer	9.41e-05	0.000639	CcSEcCtD
Simvastatin—Feeling abnormal—Doxorubicin—testicular cancer	9.36e-05	0.000635	CcSEcCtD
Simvastatin—Gastrointestinal pain—Doxorubicin—testicular cancer	9.28e-05	0.00063	CcSEcCtD
Simvastatin—Pruritus—Methotrexate—testicular cancer	9.28e-05	0.00063	CcSEcCtD
Simvastatin—Hypersensitivity—Epirubicin—testicular cancer	9.04e-05	0.000614	CcSEcCtD
Simvastatin—Urticaria—Doxorubicin—testicular cancer	9.02e-05	0.000612	CcSEcCtD
Simvastatin—Abdominal pain—Doxorubicin—testicular cancer	8.97e-05	0.000609	CcSEcCtD
Simvastatin—Body temperature increased—Doxorubicin—testicular cancer	8.97e-05	0.000609	CcSEcCtD
Simvastatin—Diarrhoea—Methotrexate—testicular cancer	8.97e-05	0.000609	CcSEcCtD
Simvastatin—Asthenia—Epirubicin—testicular cancer	8.8e-05	0.000598	CcSEcCtD
Simvastatin—Pruritus—Epirubicin—testicular cancer	8.68e-05	0.000589	CcSEcCtD
Simvastatin—Dizziness—Methotrexate—testicular cancer	8.67e-05	0.000589	CcSEcCtD
Simvastatin—Diarrhoea—Epirubicin—testicular cancer	8.39e-05	0.00057	CcSEcCtD
Simvastatin—Hypersensitivity—Doxorubicin—testicular cancer	8.36e-05	0.000568	CcSEcCtD
Simvastatin—Vomiting—Methotrexate—testicular cancer	8.34e-05	0.000566	CcSEcCtD
Simvastatin—Rash—Methotrexate—testicular cancer	8.27e-05	0.000561	CcSEcCtD
Simvastatin—Dermatitis—Methotrexate—testicular cancer	8.26e-05	0.000561	CcSEcCtD
Simvastatin—Headache—Methotrexate—testicular cancer	8.21e-05	0.000558	CcSEcCtD
Simvastatin—Asthenia—Doxorubicin—testicular cancer	8.15e-05	0.000553	CcSEcCtD
Simvastatin—Dizziness—Epirubicin—testicular cancer	8.11e-05	0.000551	CcSEcCtD
Simvastatin—Pruritus—Doxorubicin—testicular cancer	8.03e-05	0.000545	CcSEcCtD
Simvastatin—Vomiting—Epirubicin—testicular cancer	7.8e-05	0.00053	CcSEcCtD
Simvastatin—Nausea—Methotrexate—testicular cancer	7.79e-05	0.000529	CcSEcCtD
Simvastatin—Diarrhoea—Doxorubicin—testicular cancer	7.77e-05	0.000527	CcSEcCtD
Simvastatin—Rash—Epirubicin—testicular cancer	7.74e-05	0.000525	CcSEcCtD
Simvastatin—Dermatitis—Epirubicin—testicular cancer	7.73e-05	0.000525	CcSEcCtD
Simvastatin—Headache—Epirubicin—testicular cancer	7.69e-05	0.000522	CcSEcCtD
Simvastatin—Dizziness—Doxorubicin—testicular cancer	7.51e-05	0.00051	CcSEcCtD
Simvastatin—Nausea—Epirubicin—testicular cancer	7.29e-05	0.000495	CcSEcCtD
Simvastatin—Vomiting—Doxorubicin—testicular cancer	7.22e-05	0.00049	CcSEcCtD
Simvastatin—Rash—Doxorubicin—testicular cancer	7.16e-05	0.000486	CcSEcCtD
Simvastatin—Dermatitis—Doxorubicin—testicular cancer	7.15e-05	0.000485	CcSEcCtD
Simvastatin—Headache—Doxorubicin—testicular cancer	7.11e-05	0.000483	CcSEcCtD
Simvastatin—Nausea—Doxorubicin—testicular cancer	6.74e-05	0.000458	CcSEcCtD
